Wellcome Trust
Gibbs Building
215 Euston Road
London
NW1 2BE
United Kingdom
Tel: 44-0-20-7611-8888
Fax: 44-0-20-7611-8545
44 articles about Wellcome Trust
-
Wellcome and the Gates Foundation to Fund Late-Stage Development of a Tuberculosis Vaccine Candidate That Could Be the First in 100 Years If Proven Effective
6/28/2023
Wellcome and the Bill & Melinda Gates Foundation announced funding to advance a tuberculosis vaccine candidate, M72/AS01E, through a Phase III clinical trial.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 7, 2020.
-
Boston-based biotech company Karuna Pharmaceuticals completed a $42 million Series A financing. The round included the issuance of $22 million in shares upon conversion of debt into equity.
-
Boston-based PureTech Health inked a multi-year collaboration deal with Swiss-based Roche to advance PureTech’s milk-derived exosome platform technology for oral dosing of Roche’s antisense oligonucleotide platform.
-
It’s been a big year so far for activity in the U.S. biopharma market—record IPOs and plenty of big acquisitions. But things may be heating up in Europe as well.
-
The UK’s Wellcome Trust, a charitable foundation, announced it is creating the $330 million Leap Fund to invest in high-risk healthcare and life science research.
-
ClinicalStudyDataRequest.com Announces Partnerships with Global Academic Research Funders to Expand Researchers' Access to Patient-level Clinical Trial Data
4/23/2018
First-in-class online resource giving researchers access to patient-level clinical trial data from 14 of the world's leading pharmaceutical companies across multiple therapeutic areas, today announced new strategic collaborations with four major non-profit partners
-
Exonate Receives Wellcome Trust Funding To Develop Eye Drop Treatment For Wet Age-Related Macular Degeneration (Wet AMD)
2/6/2017
-
CRUK Aligns With Wellcome Trust, BACIT and Syncona to Create a $1.2 Billion Biotech Champion
11/7/2016
-
Kineta Receives Wellcome Trust Award To Advance Novel Therapeutic For Lassa Fever Into Clinical Trials
5/5/2016
-
Mucosis B.V. Secures €3.7M From Wellcome Trust To Fund Clinical Trials Of Its Respiratory Syncytial Virus Vaccine In Partnership With Imperial College London
1/19/2016
-
Wellcome Trust Release: 30 Years On CANTAB Inventors Herald The Dawn Of A New Era In Neuroscience
10/5/2015
-
Infectious Disease Research Institute (IDRI) And Wellcome Trust Team For Tuberculosis Vaccine Trial In South Africa
9/17/2015
-
Avilex Pharma Receives Wellcome Trust Translation Award To Advance Their Ischemic Stroke Program And Raises In Total 28 MIO DKK (3.75 MIO EUR)
6/8/2015
-
MERS And Ebola Replikins Synthetic Vaccine-Blocker Candidates Presented At Meeting Of Int'l Society For Neglected Tropical Diseases At Wellcome Trust May 20th
6/5/2015
-
Theraclone Sciences, Inc.' I-STAR Technology Chosen By Wellcome Trust To Identify Therapeutic Antibodies Against Ebola Virus
4/30/2015
-
Kymab And Wellcome Trust Initiate Ebola Project
12/16/2014
-
University of Birmingham Receives Grant From Wellcome Trust To Support Human Research On ChromaDex, Inc.s NIAGEN® Nicotinamide Riboside
11/17/2014
-
Omniox, Inc. Receives Wellcome Trust Translation Fund Award
10/9/2014
-
Merck Serono, Institute Of Cancer Research, Wellcome Trust To Co-Develop Cancer Drugs
10/7/2014